|
CENPL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.9248000051102E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.435100E-04 |
| Normal-vs-Stage2 |
1.455070E-03 |
| Normal-vs-Stage3 |
1.558570E-04 |
| Normal-vs-Stage4 |
3.20000000053611E-07 |
| Stage1-vs-Stage2 |
2.897400E-01 |
| Stage1-vs-Stage3 |
1.431160E-01 |
| Stage1-vs-Stage4 |
9.567500E-04 |
| Stage2-vs-Stage3 |
7.724600E-01 |
| Stage2-vs-Stage4 |
3.903800E-02 |
| Stage3-vs-Stage4 |
5.487800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.40650000535203E-08 |
| Normal-vs-AfricanAmerican |
5.263600E-01 |
| Normal-vs-Asian |
1.163420E-01 |
| Caucasian-vs-AfricanAmerican |
7.92630000000516E-05 |
| Caucasian-vs-Asian |
2.973600E-01 |
| AfricanAmerican-vs-Asian |
1.457050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.19719997541068E-09 |
| Normal-vs-Female |
1.841400E-03 |
| Male-vs-Female |
6.377200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.825570E-02 |
| Normal-vs-Age(41-60Yrs) |
1.59590000003984E-06 |
| Normal-vs-Age(61-80Yrs) |
3.42620000004512E-06 |
| Normal-vs-Age(81-100Yrs) |
5.327600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.704200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.564200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.246610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.997400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.259000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.596000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.263770E-01 |
| Normal-vs-Grade 2 |
1.637400E-03 |
| Normal-vs-Grade 3 |
1.37160000024394E-07 |
| Normal-vs-Grade 4 |
1.69451999999515E-05 |
| Grade 1-vs-Grade 2 |
9.438200E-01 |
| Grade 1-vs-Grade 3 |
3.484800E-01 |
| Grade 1-vs-Grade 4 |
1.963940E-02 |
| Grade 2-vs-Grade 3 |
8.381400E-03 |
| Grade 2-vs-Grade 4 |
2.281700E-03 |
| Grade 3-vs-Grade 4 |
6.962400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.280200E-03 |
| Normal-vs-ccB subtype |
1.26520000032215E-08 |
| ccA subtype-vs-ccB subtype |
2.383000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13520000014178E-07 |
| Normal-vs-N1 |
5.965200E-04 |
| N0-vs-N1 |
6.005500E-04 |
|
|
